Pinkdx
Indianapolis, US · Founded 2022 · Delaware corporation · 1 known investors
PinkDx develops diagnostic tools focused on gynecologic cancers, aiming to improve the diagnostic workup for conditions such as endometrial cancer. The company serves women and physicians in the U.S. by addressing clinical challenges in evaluating symptoms like abnormal or postmenopausal bleeding.
Founders & leadership
TM
Timothy McMeekanDirector
JC
Joe C Cook, IIIDirector
GK
Giulia KennedyExecutive Officer
IR
Isaac RoDirector
RS
Risa StackDirector
EW
Eric WangExecutive Officer
BA
Bonnie AndersonExecutive Officer
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$17MraisedOct 2023 · 7 investors · BiotechnologyRule 506(b)
▶$17MraisedOct 2023 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Timothy McMeekanDirector
- Joe C Cook, IIIDirector
- Giulia KennedyExecutive Officer
- Isaac RoDirector
- Risa StackDirector
- Eric WangExecutive Officer
- Bonnie AndersonExecutive Officer
- Offering amount
- $40M
- Amount sold
- $17M
- Minimum investment
- $245K
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.